Can You Claim the R&D Credit Against the AMT? (w/Examples) + FAQs

This article reflects federal rules and California rules as of June 2026 and covers tax year 2025 (the 2026 filing season). Tax law changes — confirm current figures before you file.

Quick Answer

Yes. For tax year 2025, an eligible small business — one with average gross receipts of $50 million or less over the prior three years — can claim the federal R&D credit against the alternative minimum tax (AMT). This matters mostly for individual owners of pass-through businesses, since corporate AMT no longer exists.

The reason this question even comes up is painful: before 2016, many profitable small-business owners earned a real R&D credit, then watched the alternative minimum tax block them from using a dime of it. The credit just sat there, carried forward, doing nothing while the owner wrote a check to the IRS anyway. The PATH Act of 2015 fixed this for eligible small businesses, and the fix is permanent.

The stakes are real and time-sensitive. Fewer than one in three eligible early-stage companies actually claim the R&D credit, according to a 2024 industry survey cited by Beancount.io — which means many owners who could wipe out an AMT bill never even try. If you are a partner, an S-corp shareholder, or a sole proprietor staring at AMT on your 2025 Form 1040, this is money you may be leaving on the table right now.

💸 The AMT trap explained: why the R&D credit used to vanish against AMT, and the one rule that changed it.
🏢 Who qualifies: the $50 million “eligible small business” test, plus why C-corp owners read this differently after 2017.
🧮 Worked math: real dollar examples showing exactly how the credit zeroes out an AMT bill.
📋 Forms and lines: how Form 6765, Form 3800, and Form 6251 fit together — and the deadlines that matter.
⚠️ The $500,000 payroll offset: the related rule for pre-profit startups that founders constantly confuse with the AMT question.

What the R&D Credit and the AMT Actually Are

To understand whether you can use the R&D credit against the AMT, you first need to see these as two separate machines that collide on your tax return. One is a reward for innovation. The other is a backstop that makes sure high earners pay something. The collision is what trapped taxpayers for decades.

The Credit for Increasing Research Activities — the R&D credit — lives in Internal Revenue Code Section 41. It has been part of federal law since 1981 and was made permanent by the PATH Act in 2015. It is a dollar-for-dollar credit, not a deduction. A $40,000 credit cuts your tax bill by the full $40,000, not by your tax rate times $40,000. For most small businesses, the credit equals roughly 6% to 10% of qualified research spending.

The alternative minimum tax is a parallel tax system. You calculate your tax the normal way, then recalculate it under AMT rules that strip out many deductions and credits, and you pay whichever number is higher. The gap between your regular tax and your tentative minimum tax is what determines whether AMT bites. For individuals, the AMT still exists for tax year 2025; for C corporations, the Tax Cuts and Jobs Act of 2017 repealed corporate AMT entirely starting in 2018.

The collision happens through a single rule. Most general business credits — including the R&D credit — normally cannot reduce your tax below your tentative minimum tax (TMT). So if your regular tax was $60,000 and your TMT was $58,000, the most credit you could use was $2,000, even if you earned a $40,000 credit. The other $38,000 carried forward. The PATH Act’s eligible-small-business rule rewrites that limit, and that single change is the heart of this article.

Why the C-Corp Answer Is Different

If you own a C corporation, the AMT question is largely moot, and that surprises people. Because the TCJA repealed corporate AMT for tax years beginning after December 31, 2017, a C corporation simply has no AMT for the R&D credit to fight against in 2025. The credit applies against regular corporate tax, subject to the general business credit ordering rules.

So when this article talks about “claiming the R&D credit against the AMT,” the real-world audience is the individual owner of a pass-through entity — partnerships, S corporations, and sole proprietorships — plus individuals with their own Schedule C research. Those owners still face individual AMT on Form 6251, and the PATH Act fix is what lets their R&D credit punch through it.

The PATH Act Fix: Eligible Small Businesses and AMT

The rule that makes the answer “yes” is found in IRC Section 38(c)(4) and (c)(5). It treats certain credits earned by an eligible small business (ESB) as “specified credits,” and specified credits are allowed to reduce regular tax below the tentative minimum tax. In plain English: for an ESB, the AMT wall is removed.

The consequence of not qualifying is concrete. If your business is not an ESB and you are in AMT, your R&D credit is capped at the excess of your regular tax over your TMT — often a small number or zero. The unused credit becomes a carryforward, useful only in some future year when AMT does not apply. You can wait years to cash in a credit you already earned.

Here is the mechanic in action. Maria runs a profitable design-engineering S corporation and reports a $35,000 R&D credit on her personal return. Her regular tax is $90,000 and her tentative minimum tax is $84,000. Without ESB status, she could use only $6,000 of the credit. Because her business qualifies as an ESB, the TMT limit is treated as zero for her R&D credit, and she uses the full $35,000.

A common misconception is that “eligible small business” and “qualified small business” mean the same thing. They do not. ESB status (the $50 million gross-receipts test) governs the AMT offset. QSB status (a separate $5 million test) governs the payroll-tax offset for pre-profit startups, covered later in this article. Mixing them up leads owners to claim the wrong benefit on the wrong form.

What you should do about it: confirm your three-year average gross receipts are $50 million or less, and make sure both the entity and you as the individual owner meet the test. Then claim the credit on Form 6765, flow it to Form 3800, and let the specified-credit rules lift the AMT limit automatically.

The Eligible Small Business Test in Detail

Under Section 38(c)(5)(C), an eligible small business is a non-publicly traded corporation, partnership, or sole proprietorship whose average annual gross receipts for the three preceding tax years are $50 million or less. Gross receipts are reduced by returns and allowances, and short years must be annualized. If the business existed for fewer than three years, you test the period it did exist.

The consequence of failing this test is simple but costly: no AMT offset, and your credit waits in carryforward. There is no partial credit for being “close” to $50 million — it is a bright line.

A real-world example: Devon’s manufacturing partnership averaged $46 million in gross receipts over 2022–2024, so for 2025 it is an ESB and his K-1 R&D credit can offset his personal AMT. If the same partnership had averaged $52 million, the credit would still be valid but would hit the AMT wall on Devon’s Form 6251.

A frequent misconception is that only the entity must pass the test. For partners and S-corp shareholders, both the entity and the individual must meet the $50 million gross-receipts test to use the credit against AMT at the individual level. And under the controlled-group rules, all members of a controlled group or businesses under common control are treated as a single taxpayer, so you cannot split a large company into small pieces to qualify.

What to do: pull your three prior years of gross receipts now, aggregate any related entities, and document the math before you file. Keep that calculation with your return in case the IRS asks.

Which Situation Applies to You?

The R&D-credit-versus-AMT answer depends entirely on who you are and how your business is taxed. Use this to find the part of the article that fits you, because one rule does not cover everyone.

You own a C corporation: Corporate AMT was repealed for 2018 and later, so AMT is not your obstacle. Your credit offsets regular corporate tax under the general business credit rules. Read the C-corp note above.
You are a partner or S-corp shareholder with K-1 R&D credit: This is the classic AMT case. Confirm both the entity and you meet the $50 million ESB test, then use the credit against your individual AMT.
You are a sole proprietor with Schedule C research: Same as above. Your business and you are the same taxpayer, so the single $50 million test applies to you directly.
You are a pre-revenue startup with no income tax bill: AMT is not your issue — having no tax at all is. Skip to the $500,000 payroll-tax offset section.
You earned the credit but are not an ESB: You can still claim the R&D credit; it just cannot break the AMT wall this year. Plan around the carryforward.

Worked Example: Killing an AMT Bill With the R&D Credit

Numbers make this real. Here is a fully worked example you can copy, anchored to tax year 2025 and an individual owner of a pass-through business who faces AMT on Form 6251.

Meet Priya, sole shareholder of a software S corporation. Her business averaged $9 million in gross receipts over 2022–2024, so it is an eligible small business. For 2025, the S corporation generated a $48,000 R&D credit that flows to Priya’s personal return on her K-1.

On Priya’s 2025 Form 1040:

Regular tax (before credits): $120,000
Tentative minimum tax (from Form 6251): $112,000
R&D credit available: $48,000

Step 1 — The old AMT limit (what would happen without ESB status). The general rule caps her business credit at regular tax minus TMT: $120,000 − $112,000 = $8,000. Only $8,000 of the credit would be usable; $40,000 would carry forward.

Step 2 — Apply the ESB specified-credit rule. Because Priya’s business is an ESB, her R&D credit is a specified credit, so the tentative minimum tax is treated as zero for this limit. The cap becomes regular tax minus zero = $120,000.

Step 3 — Use the full credit. Her $48,000 credit is well under the $120,000 cap, so she uses all $48,000 this year. Her tax drops from $120,000 to $72,000.

The result: ESB status turned an $8,000 benefit into a $48,000 benefit — an extra $40,000 of tax saved in 2025, instead of waiting years for a carryforward to free up.

Three Common Scenarios

These scenarios are built from the situations small-business owners run into most often. Each shows the move and what it produces.

Owner’s Situation	Outcome for 2025
S-corp shareholder, business averages $9M gross receipts, owner in AMT	ESB rule applies; full R&D credit offsets AMT this year, no carryforward needed
Partner in a partnership averaging $52M gross receipts, partner in AMT	Not an ESB; credit is valid but limited by tentative minimum tax, excess carries forward
Pre-revenue startup, 4 engineers, no income tax and no AMT	AMT is irrelevant; instead elect the $500,000 payroll-tax offset on Form 6765

The $500,000 Payroll-Tax Offset (Don’t Confuse It With AMT)

Many founders search “R&D credit against AMT” when they actually need a different rule. If your startup has no profit, your problem is not AMT — it is that you have no tax bill at all to absorb a credit. The fix is the payroll-tax offset under IRC Section 41(h), and it is separate from the ESB/AMT rule.

A qualified small business (QSB) can apply up to $500,000 per year of R&D credit against the employer portion of payroll taxes for tax year 2025. The limit was $250,000 for years before 2023; the Inflation Reduction Act doubled it to $500,000 starting with tax years beginning after December 31, 2022. The credit offsets the 6.2% employer Social Security tax first (up to $250,000), then the 1.45% employer Medicare tax for any remainder (up to another $250,000).

The consequence of qualifying is cash flow, not a refund check. The benefit shows up as reduced quarterly payroll tax payments. A 15-person engineering team with $2.4 million of payroll owes roughly $147,000 in employer FICA per year, so a $147,000 credit can erase the entire bill — real money for a runway-constrained company.

A QSB is defined narrowly: less than $5 million in gross receipts in the credit year, and no gross receipts in any tax year more than five years before the credit year. A company founded in 2022 with $2 million of 2026 revenue qualifies; a company that first had revenue in 2015 does not, because it earned revenue more than five years ago. The common misconception is that any “small” company qualifies — the five-year revenue clock disqualifies many otherwise-small firms.

What to do about it: elect the offset in Section D of Form 6765 with your timely-filed income tax return (extensions count), then claim it on Form 8974 attached to your quarterly Form 941. The first usable quarter is the one that begins after you file your return, so a return filed March 15, 2026 starts offsetting in Q2 2026. Miss the election on the original return and you generally lose it for that year.

Form-by-Form: How to Actually Claim It

Three forms carry this from calculation to tax savings. Knowing the order matters, because each one feeds the next, and a mistake on one cascades.

Form 6765, Credit for Increasing Research Activities. This is where you calculate the credit. You choose between the Regular Credit Method (20% of QREs over a base amount) and the Alternative Simplified Credit (14% of QREs over 50% of the prior three-year average, or 6% of current QREs if you had none). Most small businesses use the ASC for cleaner math. If you are a QSB electing the payroll offset, complete Section D. File Form 6765 with your income tax return; for a 2025 calendar-year return, the deadline is generally April 15, 2026, or the extended due date.

Form 3800, General Business Credit. The R&D credit flows here, where it is combined with your other business credits and where the tax-liability and AMT limitations are applied. For an eligible small business, this is where the specified-credit rule treats your tentative minimum tax as zero, lifting the AMT cap. Per the Form 3800 instructions, specified credits cannot be carried back to a year before the first year the credit was a specified credit.

Form 6251, Alternative Minimum Tax — Individuals. This is where individual owners compute the AMT itself and the tentative minimum tax that Form 3800 uses for the limit. C-corp owners skip this; corporate AMT no longer exists for 2025.

The deadline and cost picture: a DIY filer using software can prepare these forms, but the QRE calculation and documentation are where most go wrong. A specialist R&D study commonly costs a few thousand dollars for a small company and far more for larger claims, and the credit is one of the most heavily audited areas of the code, so the substantiation work usually pays for itself.

Mistakes to Avoid

Each of these errors carries a specific cost — a lost credit, a delayed benefit, or an audit adjustment.

Assuming a C corporation can “use the AMT offset.” Corporate AMT was repealed for 2018+, so there is nothing to offset; the credit simply applies to regular tax. Chasing the AMT rule wastes time.
Confusing ESB with QSB. The $50M ESB test governs AMT; the $5M QSB test governs the payroll offset. Claim the wrong one and the IRS may disallow the benefit.
Forgetting the individual must also pass the $50M test. For partners and S-corp shareholders, both the entity and the owner must qualify, or the AMT offset fails at the personal level.
Ignoring controlled-group aggregation. Splitting a business into small entities does not help; related companies are tested as one, and the IRS will combine them.
Missing the QSB payroll election on the original return. The Section D election must be on a timely-filed return (with extensions); late elections are generally not allowed, costing a full year of offset.
Claiming routine work as research. Maintenance, configuration, and routine debugging fail the four-part test, and including them invites an audit adjustment plus penalties.
Weak documentation. Companies lose valid credits because they cannot prove the technical uncertainty and experimentation; contemporaneous project records are the difference between keeping and losing the credit.
Overlooking the state credit. Stopping at the federal number leaves 5%–15% of additional benefit on the table in many states.

Do’s and Don’ts

Do’s

Do confirm your three-year average gross receipts first. It decides whether the $50M ESB rule even applies, which is the whole ballgame for AMT.
Do test the entity and the owner separately. Pass-through credits need both to qualify, or the personal AMT offset collapses.
Do keep contemporaneous documentation. Audit defense depends on records made while the work happened, not reconstructed later.
Do use the Alternative Simplified Credit when unsure. It is cleaner to compute and lighter on documentation for most small businesses.
Do check your state credit too. Many states stack their own R&D credit on top of the federal one, adding real value.

Don’ts

Don’t assume “small business” means automatic AMT relief. Only an eligible small business under the $50M test gets the offset.
Don’t mix up AMT relief with the payroll offset. They use different tests, different forms, and apply to different taxpayers.
Don’t file the QSB election late. The Section D payroll election is lost if it misses the timely return, forfeiting up to $500,000 of benefit.
Don’t claim offshore contract research. Foreign contract research generally does not qualify and can taint a claim.
Don’t ignore the carryforward rules. If you are not an ESB, plan for the credit to wait, and time future income accordingly.

Pros and Cons

Pros

Immediate tax relief. ESB status lets the credit cut tax below the tentative minimum tax, freeing cash this year instead of years from now.
Permanent rule. The PATH Act made the ESB/AMT fix permanent, so you can plan around it with confidence.
Dollar-for-dollar value. Unlike a deduction, every dollar of credit cuts a dollar of tax, magnifying the benefit.
Pairs with the payroll offset. Pre-profit startups get a parallel cash benefit through Section 41(h), so almost every stage of company has a path to value.
State stacking. Federal relief often combines with a separate state credit, increasing the total return on the same research spending.

Cons

Strict eligibility lines. The $50M and $5M bright lines mean a single dollar over the threshold can disqualify you, with no partial relief.
Heavy documentation burden. The credit is audit-prone, and weak records can erase an otherwise valid claim.
Complex ordering. Coordinating Forms 6765, 3800, and 6251 is technical, and errors cascade across forms.
Carryforward risk for non-ESBs. If you miss the ESB test, the AMT wall delays your benefit, sometimes for years.
Professional cost. A defensible R&D study often costs thousands, which can eat into a small credit.

Does My State Follow This? (California Example)

Federal rules are only half the story, and states do not automatically follow them. California is a useful example because it has a large, separate R&D program with its own rules and its own form.

California offers its own Research Credit through the Franchise Tax Board, claimed on FTB Form 3523. It generally mirrors the federal four-part test for qualified research but uses California-specific rates and a base calculation, and it applies only to research conducted in California. The state credit is non-refundable and carries forward, but California does not allow the federal payroll-tax offset, and it does not have an individual AMT structured the way the federal one is for this purpose.

The practical takeaway: run your federal R&D credit and AMT analysis first, then compute the California credit separately on Form 3523. Do not assume a number that works federally carries over — confirm the in-state research requirement and the state’s own limits before you file.

What to Do Next

Here is the ordered action plan for tax year 2025, whether your obstacle is AMT or no profit at all.

Determine your entity type and tax posture. C-corp owners focus on regular tax; pass-through owners check for AMT on Form 6251.
Calculate your three-year average gross receipts. Under $50 million unlocks the ESB/AMT offset; under $5 million (with the five-year revenue rule) unlocks the QSB payroll offset.
Identify qualifying projects and QREs for 2025 — wages, supplies, U.S. contract research at 65%, and qualifying cloud costs — and gather contemporaneous documentation.
Calculate the credit on Form 6765, usually via the Alternative Simplified Credit, and complete Section D if you are a QSB electing the payroll offset.
Flow the credit to Form 3800, where the ESB specified-credit rule lifts the AMT limit, and to Form 6251 for individual owners.
File by the deadline — generally April 15, 2026 for a 2025 calendar-year return, or the extended due date — and make any payroll election on the original, timely return.
Run your state credit separately, such as California’s Form 3523, to capture the additional benefit.

This article is educational and is not a substitute for advice from a licensed professional for your specific situation. If you own a pass-through entity facing AMT, are near the $50 million or $5 million thresholds, have controlled-group entities, or are amending prior years, bring in a CPA or tax attorney — that help typically involves a formal R&D study, an eligibility analysis, and audit-ready documentation.

FAQs

Can you claim the R&D credit against the AMT?

Yes. For tax year 2025, an eligible small business — average gross receipts of $50 million or less over the prior three years — can use the R&D credit to reduce tax below the tentative minimum tax, effectively offsetting individual AMT for pass-through owners.

What is an “eligible small business” for the AMT offset?

A non-public corporation, partnership, or sole proprietorship with average annual gross receipts of $50 million or less for the three tax years before the credit year, under IRC Section 38(c)(5)(C). Short years are annualized, and controlled groups are combined.

Do C corporations get the R&D credit against AMT?

No — because there is no corporate AMT. The TCJA repealed corporate AMT for tax years beginning after 2017, so a C corporation’s R&D credit simply offsets regular tax with no AMT wall in 2025.

What is the difference between an ESB and a QSB?

ESB ($50M test) governs the AMT offset; QSB ($5M test) governs the payroll-tax offset. They are different rules, different forms, and apply to different taxpayers. Many owners confuse them.

How much R&D credit can offset payroll taxes in 2025?

Up to $500,000 per year. A qualified small business applies the credit against the 6.2% employer Social Security tax first (up to $250,000), then the 1.45% Medicare tax for any remainder, under IRC Section 41(h).

Which form claims the R&D credit?

Form 6765. You calculate the credit there, then flow it to Form 3800 (general business credit) where tax and AMT limits apply. Individual owners also use Form 6251 to compute AMT.

What happens if I’m not an eligible small business and I’m in AMT?

Your credit is limited but not lost. It can only reduce tax down to the tentative minimum tax this year, and the unused amount carries forward to a future year when AMT does not block it.

Can a pre-revenue startup with no tax use the R&D credit?

Yes, through the payroll-tax offset. A qualified small business can apply up to $500,000 against employer payroll taxes for 2025, electing it in Section D of Form 6765 and claiming it on Form 8974.

Does both the partnership and the partner need to pass the $50M test?

Yes. For partners and S-corp shareholders, both the entity and the individual owner must meet the $50 million gross-receipts test to use the credit against AMT at the personal level.

Is the PATH Act AMT fix permanent?

Yes. The PATH Act of 2015 permanently allows eligible small businesses to use the R&D credit against AMT for tax years beginning after December 31, 2015, so you can rely on it going forward.

Does California allow the R&D credit against AMT or payroll taxes?

No to the payroll offset. California offers its own Research Credit on FTB Form 3523 for in-state research, with its own rates, but it does not follow the federal payroll-tax offset and is computed separately from the federal credit.

When is the deadline to claim the 2025 R&D credit?

Generally April 15, 2026. That is the due date for a 2025 calendar-year individual return, or the extended deadline. Any QSB payroll election must be made on a timely-filed original return, including extensions.